Clinical expression of cystic fibrosis in a large cohort of Italian siblings
Authors:
- Vito TerlizziVito Terlizzi
- Marco LucarelliMLMarco Lucarelli
- Donatello SalvatoreDSDonatello Salvatore
- Adriano AngioniAAAdriano Angioni
- Arianna BisognoABArianna Bisogno
- Cesare BraggionCBCesare Braggion
- Roberto BuzzettiRBRoberto Buzzetti
- Vincenzo CarnovaleVCVincenzo Carnovale
- Rosaria CasciaroRCRosaria Casciaro
- Giuseppe CastaldoGCGiuseppe Castaldo
- Natalia CirilliNCNatalia Cirilli
- Mirella ColluraMCMirella Collura
Open Access
- 22 December 2018
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 18 (1) , 196
Abstract
A clinical heterogeneity was reported in patients with Cystic Fibrosis (CF) with the same CFTR genotype and between siblings with CF. We investigated all clinical aspects in a cohort of 101 pairs of siblings with CF (including 6 triplets) followed since diagnosis. Severe lung disease had a 22.2% concordance in sib-pairs, occurred early and the FEV1% at 12 years was predictive of the severity of lung disease in the adulthood. Similarly, CF liver disease occurred early (median: 15 years) and showed a concordance of 27.8% in sib-pairs suggesting a scarce contribution of genetic factors; in fact, only 2/15 patients with liver disease in discordant sib-pairs had a deficiency of alpha-1-antitrypsin (a known modifier gene of CF liver phenotype). CF related diabetes was found in 22 pairs (in 6 in both the siblings). It occurred later (median: 32.5 years) and is strongly associated with liver disease. Colonization by P. aeruginosa and nasal polyposis that required surgery had a concordance > 50% in sib-pairs and were poorly correlated to other clinical parameters. The pancreatic status was highly concordant in pairs of siblings (i.e., 95.1%) but a different pancreatic status was observed in patients with the same CFTR mutations. This suggests a close relationship of the pancreatic status with the “whole” CFTR genotype, including mutations in regulatory regions that may modulate the levels of CFTR expression. Finally, a severe course of CF was evident in a number of patients with pancreatic sufficiency. Physicians involved in care of patients with CF and in genetic counseling must be aware of the clinical heterogeneity of CF even in sib-pairs that, at the state of the art, is difficult to explain.Keywords
This publication has 57 references indexed in Scilit:
- Gene Mutation in MicroRNA Target Sites of CFTR Gene: A Novel Pathogenetic Mechanism in Cystic Fibrosis?PLOS ONE, 2013
- Definitions of Pediatric Pancreatitis and Survey of Present Clinical PracticesJournal of Pediatric Gastroenterology and Nutrition, 2012
- Quantification of the Relative Contribution of Environmental and Genetic Factors to Variation in Cystic Fibrosis Lung FunctionThe Journal of Pediatrics, 2010
- Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping resultsHuman Genetics, 2009
- Genetic Modifiers Play a Substantial Role in Diabetes Complicating Cystic FibrosisThe Journal of Clinical Endocrinology & Metabolism, 2009
- Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders – updated European recommendationsEuropean Journal of Human Genetics, 2008
- Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practiceJournal of Cystic Fibrosis, 2008
- Heritability of Lung Disease Severity in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Classifying Severity of Cystic Fibrosis Lung Disease Using Longitudinal Pulmonary Function DataAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Relative Contribution of Genetic and Nongenetic Modifiers to Intestinal Obstruction in Cystic FibrosisGastroenterology, 2006